Clinical Outcomes of Hospitalized Immunocompromised Patients With COVID-19 and the Impact of Hyperinflammation: A Retrospective Cohort Study
Immunodeficiency not only increases short-term mortality risk but also predisposes patients to hyperinflammation. The complex interplay between immunosuppression, hyperinflammation, and COVID-19 outcomes warrants more detailed profiling of inflammation and immunity in this population.
Authors
- Xinjie Han
- Jiguang Meng (ORCID: https://orcid.org/0000-0001-8018-7255)
- Zhihai Han (ORCID: https://orcid.org/0000-0002-2167-2258)
- Wei Chen (ORCID: https://orcid.org/0000-0003-3461-6658)
- Xinxin Zhang (ORCID: https://orcid.org/0000-0002-6229-0029)
- Chenglong Li (ORCID: https://orcid.org/0000-0003-1970-3358)
- Lixin Xie (ORCID: https://orcid.org/0000-0002-1091-2041)
- Han Xiao-bo
- Xin Yuan
- Wuxiang Xie (ORCID: https://orcid.org/0000-0001-7527-1022)
- Junchang Cui
- Junchen Xiong
Institutions
- Anhui Medical University (CN)
- Peking University (CN)
- Chinese PLA General Hospital (CN)
- Peking University First Hospital (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2025-03-01
- DOI
- https://doi.org/10.2147/jir.s482940
- Citations
- 2
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.79